Major Adverse Cardiovascular Events Following Coronary Artery Stenting by History of Hypertensive Disorder of Pregnancy.

MACE PCI cardiovascular disease complications preeclampsia

Journal

Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524

Informations de publication

Date de publication:
11 Oct 2024
Historique:
medline: 11 10 2024
pubmed: 11 10 2024
entrez: 11 10 2024
Statut: aheadofprint

Résumé

A history of hypertensive disorders of pregnancy is associated with at least twice the risk of incident ischemic heart disease. Whether the long-term outcome following treatment with coronary artery stenting is associated to the history of hypertensive disorders of pregnancy is unknown. We included 8364 women (age ≤65 years) undergoing first coronary artery stenting 2006 to 2022 following their first delivery in 1973 or later, linking nationwide data on percutaneous coronary intervention and delivery history. In total, 1122 women (13.4%) had a history of hypertensive disorders of pregnancy. The main outcome, a major adverse cardiovascular event, was defined as any incident myocardial infarction, ischemic heart disease, cardiac arrest, arrhythmias, angina pectoris, heart failure, cerebral infarction, or sudden death. During a median follow-up time of 5 years, 258 women with a history of hypertensive disorders of pregnancy had a major adverse cardiovascular event, compared with 1465 women without a history of hypertensive disorders of pregnancy (23% versus 20.2%, Women with a history of hypertensive disorders of pregnancy have an increased risk of a major adverse cardiovascular event following coronary artery stenting compared with other parous women. A history of hypertensive disorders of pregnancy warrants further attention in the secondary prevention setting of coronary artery disease.

Sections du résumé

BACKGROUND BACKGROUND
A history of hypertensive disorders of pregnancy is associated with at least twice the risk of incident ischemic heart disease. Whether the long-term outcome following treatment with coronary artery stenting is associated to the history of hypertensive disorders of pregnancy is unknown.
METHODS AND RESULTS RESULTS
We included 8364 women (age ≤65 years) undergoing first coronary artery stenting 2006 to 2022 following their first delivery in 1973 or later, linking nationwide data on percutaneous coronary intervention and delivery history. In total, 1122 women (13.4%) had a history of hypertensive disorders of pregnancy. The main outcome, a major adverse cardiovascular event, was defined as any incident myocardial infarction, ischemic heart disease, cardiac arrest, arrhythmias, angina pectoris, heart failure, cerebral infarction, or sudden death. During a median follow-up time of 5 years, 258 women with a history of hypertensive disorders of pregnancy had a major adverse cardiovascular event, compared with 1465 women without a history of hypertensive disorders of pregnancy (23% versus 20.2%,
CONCLUSIONS CONCLUSIONS
Women with a history of hypertensive disorders of pregnancy have an increased risk of a major adverse cardiovascular event following coronary artery stenting compared with other parous women. A history of hypertensive disorders of pregnancy warrants further attention in the secondary prevention setting of coronary artery disease.

Identifiants

pubmed: 39392150
doi: 10.1161/JAHA.124.035448
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e035448

Auteurs

Omar Sigurvin Gunnarsson (OS)

Perinatal and Cardiovascular Epidemiology, Lund University Diabetes Centre, Clinical Sciences Malmö Lund University Malmö Sweden.
Department of Obstetrics and Gynecology Skåne University Hospital Lund, Malmö Sweden.

Mats Pihlsgård (M)

Perinatal and Cardiovascular Epidemiology, Lund University Diabetes Centre, Clinical Sciences Malmö Lund University Malmö Sweden.

Moa Handmark (M)

Perinatal and Cardiovascular Epidemiology, Lund University Diabetes Centre, Clinical Sciences Malmö Lund University Malmö Sweden.

Giovanna Sarno (G)

Department of Medical Sciences, Cardiology and Uppsala Clinical Research Center Uppsala University Uppsala Sweden.

Isabel Gonçalves (I)

Department of Cardiology and Cardiovascular Research Translational Studies, Clinical Sciences Malmö Lund University Malmö Sweden.

Simon Timpka (S)

Perinatal and Cardiovascular Epidemiology, Lund University Diabetes Centre, Clinical Sciences Malmö Lund University Malmö Sweden.
Department of Obstetrics and Gynecology Skåne University Hospital Lund, Malmö Sweden.

Classifications MeSH